Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RIP2 Kinase Inhibitor 4 is a highly potent and selective RIPK2 PROTAC compound that efficiently degrades RIPK2 (with a pIC50 value of 8) and effectively inhibits the release of TNF-α.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | Inquiry |
Description | RIP2 Kinase Inhibitor 4 is a highly potent and selective RIPK2 PROTAC compound that efficiently degrades RIPK2 (with a pIC50 value of 8) and effectively inhibits the release of TNF-α. |
In vitro | RIP2 Kinase Inhibitor 4 (Compound 20) is a novel inhibitor that targets the apoptosis (IAP) binder, displaying lower binding efficiency to the cIAP1 and XIAP BIR3 domains while showing enhanced binding to the XIAP BIR2 domain[1]. Moreover, this compound demonstrates the ability to recruit IAP E3 ligases, significantly diminishing its suppression of muramyl dipeptide (MDP)-induced TNFα production in human peripheral blood mononuclear cells (PBMCs), indicated by a pIC50 value of 9.3[1]. |
In vivo | The initial in vivo evaluation of RIP2 Kinase Inhibitor 4 (Compound 20) in rats, administered subcutaneously at a dose of 0.5 mg/kg, showed significant degradation of RIPK2 and suppression of MDP-induced TNFα release after 48 hours[1]. |
Molecular Weight | 1045.23 |
Formula | C50H66F2N14O7S |
CAS No. | 2126803-41-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RIP2 Kinase Inhibitor 4 2126803-41-4 RIP-2 Kinase Inhibitor 4 inhibitor inhibit